Page 12 - காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In காரணிகள் அந்த இருக்கலாம் செயல்விளைவு உண்டுபண்ணு எதிர்கால Today - Breaking & Trending Today

BioNTech SE: Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY

New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million dosesAdditional dose deliveries beginning December 2021 through 2023Pfizer ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Andrew Widger , Chuck Triano , Ugur Sahin , Fosun Pharma , Pfizer Inc Nasdaq , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , European Union , European Medicines Agency , Roche Group , Chief Executive Officer , Marketing Authorization Holder , Product Characteristics , Package Leaflet , Breakthroughs That Change Patient , Pfizer News , Biologics License Application , Annual Report , Looking Information , Factors That May Affect Future ,

Pfizer Inc.: Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY

Pfizer Inc.: Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY
Additional dose deliveries beginning December 2021 through 2023
Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY to the EC since the beginning of the pandemic
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY
, the companies COVID-19 vaccine, to the European Union (EU), with an option for the EC to request up to an additional 900 million doses.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210520005450/en/ ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Andrew Widger , Ugur Sahin , Fosun Pharma , Centers For Disease , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Chief Executive Officer , Marketing Authorization Holder , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Disease Control , Adverse Events ,

BioNTech SE: Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine

(0)
ISTANBUL, TURKEY and MAINZ, GERMANY,
May 20, 2021(Nasdaq: BNTX) today announced that the BioNTech Europe GmbH has entered into an agreement with Turkey s Ministry of Health to supply 60 million additional doses of the companies COVID-19 vaccine, with an option for an additional 30 million doses. On December 25, 2020, the two companies announced an initial agreement to provide 30 million doses of the Pfizer-BioNTech vaccine to Turkey. This second supply agreement brings the total number of doses to be supplied to Turkey to up to 120 million, all of which will be delivered in 2021.
Our goal is to deliver as many doses of our COVID-19 vaccine as possible to people around the world to help end this pandemic, reduce COVID-19-related hospitalisations and return to a normal life. We are grateful to be able to make an important contribution to Turkey s vaccination efforts and for the trust placed in us, said ....

United States , United Kingdom , Biontech Europe Gmb , Sylke Maas , Chuck Triano , Andrew Widger , Ugur Sahin , Fosun Pharma , Centers For Disease , Administration Under Emergency Use Authorization , Bayer Animal Health , Exchange Commission , Turkey Ministry Of Health , European Union , Roche Group , Europe Gmbh , Pfizer Country Manager , Marketing Authorization Holder , Emergency Use Authorization , Disease Control , Adverse Events , Fact Sheet , Mandatory Requirements , Emergency Use , Breakthroughs That Change Patient , Pfizer News ,

Investegate |BioNTech SE Announcements | BioNTech SE: Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®

BioNTech SE
Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million doses
Additional dose deliveries beginning December 2021 through 2023
Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY® to the EC since the beginning of the pandemic
NEW YORK AND MAINZ, GERMANY, May 20, 2021 Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Andrew Widger , Ugur Sahin , Fosun Pharma , Biontech To Supply The European Union , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , European Medicines Agency , Roche Group , Additional Doses , Chief Executive Officer , Marketing Authorization Holder , Product Characteristics , Package Leaflet , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine ,

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®

Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®
New agreement to supply 900 million doses to the European Commission with option to request up to an additional 900 million doses Additional dose deliveries beginning December 2021 through 2023 Pfizer and BioNTech have now committed a total of up to 2.4 billion doses of COMIRNATY® to the EC since the beginning of the pandemic Pfizer Inc. and BioNTech SE today announced a new agreement with the European Commission …
New agreement to supply 900 million doses to the European Commission (EC), with option to request up to an additional 900 million doses ....

United States , United Kingdom , Sylke Maas , Albert Bourla , Chuck Triano , Andrew Widger , Ugur Sahin , Fosun Pharma , Centers For Disease , European Commission , Drug Administration , Bayer Animal Health , Exchange Commission , Pfizer Inc , European Union , Roche Group , Vaccine Administration Under Emergency Use Authorization , Chief Executive Officer , Marketing Authorization Holder , Emergency Use Authorization , Coronavirus Disease , Fact Sheet , Healthcare Providers Administering Vaccine , Vaccination Providers , Disease Control , Adverse Events ,